Table 2.
Variable | Group | Mean | SD | p-value |
---|---|---|---|---|
Age (years) | Experimental Control | 39.69 | 8.13 | |
42.78 | 7.38 | 0.061 | ||
Sex | Experimental Control | Women 54.2 % (n = 13) | ||
Men 45.8% (n = 11) | ||||
Women 60.9% (n = 14) | ||||
Men 9.1 % (n = 9) | ||||
Years since diagnosis | Experimental Control | 9.68 | 6.76 | |
10.86 | 5.40 | 0.142 | ||
MS type | Experimental Control | PP 20.0 % (n = 5) | ||
RR 71.9 % (n = 16) | ||||
SP 8.1 % (n = 3) | ||||
PP 8.7% (n = 2) | ||||
RR 65.2% (n = 15) | ||||
SP 26.1% (n = 6) | ||||
EDSS | Experimental Control | Score 3 EDSS 16.4 % (n = 4) | ||
Score 4 EDSS 75.5 % (n = 17) | ||||
Score 5 EDSS 8.1 % (n = 3) | ||||
Score 3 EDSS 21.7 % (n = 5) | ||||
Score 4 EDSS 60.9 % (n = 14) | ||||
Score 5 EDSS 17.4 % (n = 4) |
MS: Multiple Sclerosis; PP: Primary Progressive; RR: Relapsing Remitting; SP: Secondary Progressive.